TY - JOUR T1 - Evaluation of County-Level Heterogeneity in Excess Mortality in Colorado from March to September 2020 JF - medRxiv DO - 10.1101/2021.04.10.21255235 SP - 2021.04.10.21255235 AU - Jay Chandra AU - Marie Charpignon AU - Mathew C. Samuel AU - Anushka Bhaskar AU - Saketh Sundar AU - Kirk Bol AU - Yuan Lai AU - Leo A. Celi AU - Sema K. Sgaier AU - Grace Charles AU - Maimuna S. Majumder Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/17/2021.04.10.21255235.abstract N2 - Importance Tracking the direct and indirect impact of the coronavirus disease 2019 (COVID-19) pandemic on all-cause mortality in the United States has been hindered by the lack of testing and by reporting delays. Evaluating excess mortality, or the number of deaths above what is expected in a given time period, provides critical insights into the true burden of the COVID-19 pandemic caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Stratifying mortality data by demographics such as age, sex, race, ethnicity, and geography helps quantify how subgroups of the population have been differentially affected. Similarly, stratifying mortality data by cause of death reveals the public health effects of the pandemic in terms of other acute and chronic diseases.Objective To provide stratified estimates of excess mortality in Colorado from March to September 2020.Design, Setting, and Population This study evaluated the number of excess deaths both directly due to SARS-CoV-2 infection and from all other causes between March and September 2020 at the county level in Colorado. Data were obtained from the Vital Statistics Program at the Colorado Department of Public Health and Environment. These estimates of excess mortality were derived by comparing population-adjusted mortality rates in 2020 with rates in the same months from 2015 to 2019.Results We found evidence of excess mortality in Colorado between March and September 2020. Two peaks in excess deaths from all causes were recorded in the state, one mid-April and the other at the end of June. Since the first documented SARS-CoV-2 infection on March 5th, we estimated that the excess mortality rate in Colorado was two times higher than the officially reported COVID-19 mortality rate. State-level cumulative excess mortality from all causes reached 71 excess deaths per 100k residents (∼4000 excess deaths in the state); in contrast, 35 deaths per 100k directly due to SARS-CoV-2 were recorded in the same period (∼1980 deaths. Excess mortality occurred in 52 of 64 counties, accounting for 99% of the state’s population. Most excess deaths recorded from March to September 2020 were associated with acute events (estimated at 44 excess deaths per 100k residents and at 9 after excluding deaths directly due to SARS-CoV-2) rather than with chronic conditions (∼21 excess deaths per 100k). Among Coloradans aged 14-44, 1.4 times more deaths occurred in those months than during the same period in the five previous years. Hispanic White males died of COVID-19 at the highest rate during this time (∼90 deaths from COVID-19 per 100k residents); however, Non-Hispanic Black/African American males were the most affected in terms of overall excess mortality (∼204 excess deaths per 100k). Beyond inequalities in COVID-19 mortality per se, these findings signal considerable regional and racial-ethnic disparities in excess all-cause mortality that need to be addressed for a just recovery and in future public health crises.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was recieved.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data was obtained in accordance with CDPHE's policy for data sharing.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll analyses were run using Python 3.7.1. All scripts used for analyses, as well as aggregated data, are located on the following Github repository: https://github.com/jaychandra3/excess_mortality_CO. https://github.com/jaychandra3/excess_mortality_CO ER -